Rejuvel Bio-Sciences (NUUU) Stock Overview
A development stage company, produces, distributes, markets, and sells skin care products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
NUUU Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
Rejuvel Bio-Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | 0% |
| 5 Year Change | -99.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
Shareholder Returns
| NUUU | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | -3.8% | -3.7% |
| 1Y | 0% | -18.8% | 11.0% |
Return vs Industry: NUUU exceeded the US Personal Products industry which returned -18.9% over the past year.
Return vs Market: NUUU underperformed the US Market which returned 11.9% over the past year.
Price Volatility
| NUUU volatility | |
|---|---|
| NUUU Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 10.4% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: NUUU's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine NUUU's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Charles Scimeca | www.rejuvel.com |
Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand. It also intends to develop, build, and sell environmental management solutions that use electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities.
Rejuvel Bio-Sciences, Inc. Fundamentals Summary
| NUUU fundamental statistics | |
|---|---|
| Market cap | US$8.84k |
| Earnings (TTM) | -US$1.05m |
| Revenue (TTM) | US$187.33k |
Is NUUU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NUUU income statement (TTM) | |
|---|---|
| Revenue | US$187.33k |
| Cost of Revenue | US$98.52k |
| Gross Profit | US$88.81k |
| Other Expenses | US$1.14m |
| Earnings | -US$1.05m |
Last Reported Earnings
Sep 30, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did NUUU perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 10:52 |
| End of Day Share Price | 2025/11/17 00:00 |
| Earnings | 2015/09/30 |
| Annual Earnings | 2014/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Rejuvel Bio-Sciences, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.